June 11, 2026
Argenica Therapeutics (ASX:AGN) secures INN for lead neuroprotective candidate
WHO confirms “xaranetide” as the International Nonproprietary Name for Argenica’s lead neuroprotective candidate, ARG-007.
WHO confirms “xaranetide” as the International Nonproprietary Name for Argenica’s lead neuroprotective candidate, ARG-007.